Institutional Sign In

Go

ROSSMANN Czech Republic

ROSSMANN CR's Cash & Cash Equivalents rose 28.6% yoy to CZK 49.9 mil in 2017

By Helgi Library - April 2, 2020

ROSSMANN Czech Republic's total assets reached CZK 981 mil at the end of 2017, down 10.4% compared to the previous year. ...

ROSSMANN CR's Cash & Cash Equivalents rose 28.6% yoy to CZK 49.9 mil in 2017

By Helgi Library - April 2, 2020

ROSSMANN Czech Republic's total assets reached CZK 981 mil at the end of 2017, down 10.4% compared to the previous year. ...

Profit Statement 2015 2016 2017
Sales CZK mil 2,693 2,738 2,724
Gross Profit CZK mil 402 427 355
EBITDA CZK mil 127 119 60.5
EBIT CZK mil 39.2 36.2 -12.1
Financing Cost CZK mil 26.3 18.6 19.1
Pre-Tax Profit CZK mil 12.9 17.6 -31.2
Net Profit CZK mil 3.85 14.9 -56.7
Dividends CZK mil 0 0 ...
Balance Sheet 2015 2016 2017
Total Assets CZK mil 1,133 1,096 981
Non-Current Assets CZK mil 217 197 154
Current Assets CZK mil 906 887 815
Working Capital CZK mil 567 657 590
Shareholders' Equity CZK mil 282 297 240
Liabilities CZK mil 851 799 741
Total Debt CZK mil 447 428 351
Net Debt CZK mil 409 389 301
Ratios 2015 2016 2017
ROE % 1.38 5.16 -21.1
ROCE % 0.476 1.82 -7.09
Gross Margin % 14.9 15.6 13.0
EBITDA Margin % 4.70 4.33 2.22
EBIT Margin % 1.46 1.32 -0.444
Net Margin % 0.143 0.545 -2.08
Net Debt/EBITDA 3.23 3.28 4.98
Net Debt/Equity % 145 131 126
Cost of Financing % 5.37 4.25 4.91
Cash Flow 2015 2016 2017
Total Cash From Operations CZK mil 137 75.4 123
Total Cash From Investing CZK mil -36.0 -55.5 -36.0
Total Cash From Financing CZK mil 60.0 -39.3 -70.0
Net Change In Cash CZK mil 161 -19.4 17.2
Cash Conversion Cycle days 88.5 99.6 88.2
Cash Earnings CZK mil 91.4 97.4 15.9
Free Cash Flow CZK mil 101 19.9 87.2

Get all company financials in excel:

Download Sample   $19.99

summary Unit 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
income statement                      
Sales CZK mil         2,592 2,741 2,715 2,672 2,693    
Gross Profit CZK mil         380 379 363 379 402    
EBIT CZK mil         27.3 45.7 4.90 29.9 39.2    
Net Profit CZK mil         25.6 16.8 -23.7 6.46 3.85    
ROE %         13.0 7.69 -11.0 2.69 1.38    
EBIT Margin %         1.06 1.67 0.180 1.12 1.46    
Net Margin %         0.987 0.612 -0.872 0.242 0.143    
Employees         635 665 642 640 639    
balance sheet                      
Total Assets CZK mil         1,191 1,479 1,197 1,194 1,133    
Non-Current Assets CZK mil         278 311 301 274 217    
Current Assets CZK mil         897 1,142 884 909 906    
Shareholders' Equity CZK mil         210 226 203 278 282    
Liabilities CZK mil         981 1,253 994 916 851    
Non-Current Liabilities CZK mil         22.1 9.47 2.61 0 0    
Current Liabilities CZK mil         365 575 369 359 382    
Net Debt/EBITDA         4.89 4.57 5.81 4.26 3.23    
Net Debt/Equity %         260 276 283 183 145    
Cost of Financing % ...       4.69 4.09 4.71 4.17 5.37    
cash flow                      
Total Cash From Operations CZK mil         -16.7 45.3 137 54.7 137    
Total Cash From Investing CZK mil         -119 -124 -85.8 -63.7 -36.0    
Total Cash From Financing CZK mil         -12.6 -12.6 40.5 369 60.0    
Net Change In Cash CZK mil         -148 -91.1 91.4 360 161    
income statement Unit 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
income statement                      
Sales CZK mil         2,592 2,741 2,715 2,672 2,693    
Cost of Goods & Services CZK mil         2,212 2,362 2,352 2,293 2,292    
Gross Profit CZK mil         380 379 363 379 402    
Staff Cost CZK mil         258 271 267 264 273    
Other Cost CZK mil         10.4 -27.6 -2.27 -4.69 2.19    
EBITDA CZK mil         112 136 98.6 120 127    
Depreciation CZK mil         84.2 90.7 93.7 89.8 87.5    
EBIT CZK mil         27.3 45.7 4.90 29.9 39.2    
Financing Cost CZK mil         24.6 25.1 29.3 23.5 26.3    
Extraordinary Cost CZK mil         0 0 0 0 0    
Pre-Tax Profit CZK mil         2.80 20.6 -24.4 6.46 12.9    
Tax CZK mil         -22.8 3.80 -0.707 -0.005 9.05    
Minorities CZK mil         0 0 0 0 0    
Net Profit CZK mil         25.6 16.8 -23.7 6.46 3.85    
Dividends CZK mil ... ... ... ... ... ... ... ... 0   ...
growth rates                      
Total Revenue Growth % ...       2.85 5.75 -0.958 -1.58 0.796    
Operating Cost Growth % ...       10.8 -9.57 8.82 -1.84 5.87    
EBITDA Growth % ...       -2.55 22.3 -27.7 21.4 5.86    
EBIT Growth % ...       -20.9 67.1 -89.3 511 30.9    
Pre-Tax Profit Growth % ...       -73.1 636 -219 -126 99.7    
Net Profit Growth % ...       12.8 -34.5 -241 -127 -40.4    
ratios                      
ROE %         13.0 7.69 -11.0 2.69 1.38    
ROCE % ...       3.44 1.97 -2.68 0.760 0.476    
Gross Margin %         14.7 13.8 13.4 14.2 14.9    
EBITDA Margin %         4.30 4.98 3.63 4.48 4.70    
EBIT Margin %         1.06 1.67 0.180 1.12 1.46    
Net Margin %         0.987 0.612 -0.872 0.242 0.143    
Payout Ratio % ... ... ... ... ... ... ... ... 0   ...
Cost of Financing % ...       4.69 4.09 4.71 4.17 5.37    
Net Debt/EBITDA         4.89 4.57 5.81 4.26 3.23    
balance sheet Unit 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
balance sheet                      
Non-Current Assets CZK mil         278 311 301 274 217    
Property, Plant & Equipment CZK mil         261 290 283 256 201    
Intangible Assets CZK mil         16.8 21.0 18.0 18.2 15.2    
Current Assets CZK mil         897 1,142 884 909 906    
Inventories CZK mil         636 891 679 704 676    
Receivables CZK mil         59.0 82.5 72.4 47.0 76.3    
Cash & Cash Equivalents CZK mil         35.4 24.5 21.5 22.3 38.1    
Total Assets CZK mil         1,191 1,479 1,197 1,194 1,133    
Shareholders' Equity CZK mil         210 226 203 278 282    
Of Which Minority Interest CZK mil         0 0 0 0 0    
Liabilities CZK mil         981 1,253 994 916 851    
Non-Current Liabilities CZK mil         22.1 9.47 2.61 0 0    
Long-Term Debt CZK mil         22.1 9.47 2.61 0 0    
Deferred Tax Liabilities CZK mil         0 0 0 0 0    
Current Liabilities CZK mil         365 575 369 359 382    
Short-Term Debt CZK mil         558 639 592 532 447    
Trade Payables CZK mil         166 388 185 192 185    
Provisions CZK mil         25.9 11.0 22.7 17.6 15.5    
Equity And Liabilities CZK mil         1,191 1,479 1,197 1,194 1,133    
growth rates                      
Total Asset Growth % ...       19.7 24.2 -19.1 -0.233 -5.16    
Shareholders' Equity Growth % ...       13.9 8.00 -10.5 37.2 1.38    
Net Debt Growth % ...       23.1 14.4 -8.17 -10.9 -19.8    
Total Debt Growth % ...       24.4 11.6 -8.33 -10.4 -16.0    
ratios                      
Total Debt CZK mil         581 648 594 532 447    
Net Debt CZK mil         545 624 573 510 409    
Working Capital CZK mil         529 586 567 559 567    
Capital Employed CZK mil         807 897 868 833 784    
Net Debt/Equity %         260 276 283 183 145    
Cost of Financing % ...       4.69 4.09 4.71 4.17 5.37    
cash flow Unit 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
cash flow                      
Net Profit CZK mil         25.6 16.8 -23.7 6.46 3.85    
Depreciation CZK mil         84.2 90.7 93.7 89.8 87.5    
Non-Cash Items CZK mil ...       -40.2 -5.00 47.8 -49.3 53.7    
Change in Working Capital CZK mil ...       -86.3 -57.1 18.9 7.80 -8.24    
Total Cash From Operations CZK mil         -16.7 45.3 137 54.7 137    
Capital Expenditures CZK mil         -119 -124 -85.8 -63.7 -36.0    
Other Investments CZK mil         0 0 0 0 0.007    
Total Cash From Investing CZK mil         -119 -124 -85.8 -63.7 -36.0    
Dividends Paid CZK mil ... ... ... ... ... ... ... ... 0   ...
Issuance Of Shares CZK mil ... ... ... ... ... ... ... ... ...    
Issuance Of Debt CZK mil ...       114 67.6 -54.0 -61.9 -85.0    
Total Cash From Financing CZK mil         -12.6 -12.6 40.5 369 60.0    
Net Change In Cash CZK mil         -148 -91.1 91.4 360 161    
ratios                      
Days Sales Outstanding days         8.30 11.0 9.73 6.42 10.3    
Days Sales Of Inventory days         105 138 105 112 108    
Days Payable Outstanding days         27.5 59.9 28.7 30.6 29.5    
Cash Conversion Cycle days         85.8 88.8 86.5 87.9 88.5    
Cash Earnings CZK mil         110 107 70.0 96.2 91.4    
Free Cash Flow CZK mil         -135 -78.5 50.9 -8.91 101    
other data Unit 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
other data                      
ROA %         2.34 1.26 -1.77 0.541 0.331    
Gross Margin %         14.7 13.8 13.4 14.2 14.9    
Employees         635 665 642 640 639    
Cost Per Employee USD per month         1,918 1,734 1,770 1,611 1,490    
Cost Per Employee (Local Currency) CZK per month         33,917 33,925 34,629 34,420 35,566    
Staff Cost (As % Of Total Cost) %         10.1 10.0 9.84 10.0 10.3    
Effective Tax Rate %         -816 18.5 2.90 -0.077 70.1    
Capital Expenditures (As % of Sales) %         4.58 4.52 3.16 2.38 1.34    
Revenues From Abroad CZK mil ... ... ... ... ... ... ... ... ...    
Revenues From Abroad (As % Of Total) % ... ... ... ... ... ... ... ... ...    

Get all company financials in excel:

Download Sample   $19.99

ROSSMANN s.r.o. is a Czech Republic-based subsidiary of the German Dirk Rossmann GmbH . The Czech subsidiary was founded in 1994. In the middle of 2015, the Company was operating 124 drug stores on the Czech market. Dirk Rossmann GmbH operates a chain of health and beauty product stores in Germany, Poland, Hungary, and the Czech Republic. The company also provides over-the-counter drugs through Internet. Dirk Rossmann GmbH was founded in 1972 and is based in Burgwedel, Germany.

Finance

ROSSMANN Czech Republic has been growing its sales by a year on average in the last 5 years. EBITDA has fallen on average by 15% a year during that time to total of CZK 60.5 mil in 2017, or 2.22% of sales. That’s compared to 3.87% average margin seen in last five years.

The company netted CZK -56.7 mil in 2017 implying ROE of -21.1% and ROCE of -7.09%. Again, the average figures were -4.59% and -1.34%, respectively when looking at the previous 5 years.

ROSSMANN Czech Republic’s net debt amounted to CZK 301 mil at the end of 2017, or 126% of equity. When compared to EBITDA, net debt was 4.98x, up when compared to average of 4.31x seen in the last 5 years.